InvestorsHub Logo
Followers 1082
Posts 27318
Boards Moderated 11
Alias Born 01/11/2016

Re: None

Saturday, 05/02/2020 1:13:55 PM

Saturday, May 02, 2020 1:13:55 PM

Post# of 76
ERYP, market makers want $60.00 dollars per share for this, anything between here and 60 dollars are all traders, watch this thing slowly creep up to that price target in the coming months. One of the best biotechs out there with a legitimate shot of approval for Pancreatic Cancer Treatment, already at phase 3 and fast track designation from the FDA. When this starts to run, it will be similar pattern to CR*TX, which had the same share structure, thinly traded and tightly held stocks are the best.